Vascular BioSciences – Providing Solutions for Vascular-based Diseases

Skip Navigation

VBS movie Flash place holder

Get macromedia Flash Player

VBS Interventional

VBS Molecular Diagnostics

VBS Pharmaceuticals

Develops and manufactures the endoarterial biopsy catheter, the world’s first minimally invasive catheter designed to obtain biopsy samples from the inner layers of arteries percutaneously.

Provides diagnostic services for the detection and characterization of vascular-based diseases in order to produce a comprehensive profile of vascular disease.

VBS Pharmaceuticals, a majority owned subsidiary of Vascular BioSciences, advances targeted therapies in order to improve outcomes for patients with difficult to treat diseases.

June 10, 2011 – VBS Pharma announces publication of “Peptide-Directed Highly Selective Targeting of Pulmonary Arterial Hypertension”